In just over a year since its US Food and Drug Administration (FDA) approval, pirtobrutinib (Jayprica) has become a standard ...

An Enniskillen-based man will this week share his chemotherapy journey in a festival performance to raise funds for cancer ...

An Enniskillen-based man will this week share his chemotherapy journey in a festival performance to raise funds for cancer ...

DelveInsight’s Non-Hodgkin Lymphoma pipeline report depicts a robust space with 200+ Non-Hodgkin Lymphoma companies working ...

Wojciech Jurczak, MD, PhD, ​​discusses the future of B-cell lymphoma therapy, with a focus on Bruton's tyrosine kinase ...

This approval augments Biocon Pharma's complex injectables portfolio and reinforces its footprint in the US pharma market.

Wojciech Jurczak, MD, PhD, discusses advancements in B-cell lymphoma therapy, focusing on immunotherapy, molecular-targeted agents, and more.

In a case report published in the World Journal of Oncology, an elderly female patient was diagnosed with mast cell leukemia (MCL), with imaging showing extensive osteoblastic metastatic lesions. MCL ...

An app told Brian O'Sullivan he had cancer. 'And that started my love-hate relationship with technology,' he says.

Bristol Myers Squibb gets European Commission approval to expand use of CAR T cell therapy, Breyanzi for relapsed or refractory follicular lymphoma: Princeton, New Jersey Monday, ...

A statement was issued on the Scottish Hospitals Inquiry website on Wednesday evening branding the under-fire Glasgow ...

Like other cancers, diffuse large B-cell lymphoma starts when the DNA in cells changes in ways that allow the cells to multiply out of control. Researchers don’t know why this happens in most ...